Novo Nordisk (NVO) released clinical trial results for its potential Ozempic successor on Monday, disappointing Wall Street for the second time.
Read more...
Read More Details
Finally We wish PressBee provided you with enough information of ( Novo Nordisk's Ozempic successor disappointed Wall Street, again )
Also on site :
- Trump economic advisor confident in China trade deal conclusion on Monday
- Trump advisor expects China trade deal conclusion Monday
- Игра и не только: вклад Haier в будущее молодежи и устойчивое развитие